Logo image of APTO

APTOSE BIOSCIENCES INC (APTO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:APTO - CA03835T4081 - Common Stock

1.71 USD
-1.44 (-45.71%)
Last: 4/1/2025, 8:17:01 PM
2.16 USD
+0.45 (+26.32%)
After Hours: 4/1/2025, 8:17:01 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to APTO. APTO was compared to 533 industry peers in the Biotechnology industry. APTO has a bad profitability rating. Also its financial health evaluation is rather negative. APTO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

APTO had negative earnings in the past year.
APTO had a negative operating cash flow in the past year.
APTO had negative earnings in each of the past 5 years.
In the past 5 years APTO always reported negative operating cash flow.
APTO Yearly Net Income VS EBIT VS OCF VS FCFAPTO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

The Return On Assets of APTO (-327.57%) is worse than 95.09% of its industry peers.
Industry RankSector Rank
ROA -327.57%
ROE N/A
ROIC N/A
ROA(3y)-185.13%
ROA(5y)-125.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
APTO Yearly ROA, ROE, ROICAPTO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K 1.5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for APTO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
APTO Yearly Profit, Operating, Gross MarginsAPTO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

There is no outstanding debt for APTO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
APTO Yearly Shares OutstandingAPTO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
APTO Yearly Total Debt VS Total AssetsAPTO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

APTO has an Altman-Z score of -79.84. This is a bad value and indicates that APTO is not financially healthy and even has some risk of bankruptcy.
APTO's Altman-Z score of -79.84 is on the low side compared to the rest of the industry. APTO is outperformed by 95.96% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -79.84
ROIC/WACCN/A
WACCN/A
APTO Yearly LT Debt VS Equity VS FCFAPTO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.05 indicates that APTO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.05, APTO is doing worse than 87.89% of the companies in the same industry.
APTO has a Quick Ratio of 1.05. This is a normal value and indicates that APTO is financially healthy and should not expect problems in meeting its short term obligations.
APTO has a worse Quick ratio (1.05) than 86.32% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
APTO Yearly Current Assets VS Current LiabilitesAPTO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

APTO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -237.66%.
EPS 1Y (TTM)-237.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.15%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 17.16% on average over the next years. This is quite good.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y91.43%
EPS Next 2Y38.98%
EPS Next 3Y26.36%
EPS Next 5Y17.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
APTO Yearly Revenue VS EstimatesAPTO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 100M 200M 300M 400M 500M
APTO Yearly EPS VS EstimatesAPTO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -100 -200 -300 -400 -500

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

APTO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for APTO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
APTO Price Earnings VS Forward Price EarningsAPTO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
APTO Per share dataAPTO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -5 -10 -15 -20 -25

4.3 Compensation for Growth

A more expensive valuation may be justified as APTO's earnings are expected to grow with 26.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.98%
EPS Next 3Y26.36%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for APTO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

APTOSE BIOSCIENCES INC

NASDAQ:APTO (4/1/2025, 8:17:01 PM)

After market: 2.16 +0.45 (+26.32%)

1.71

-1.44 (-45.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-28 2025-03-28/bmo
Earnings (Next)05-12 2025-05-12/amc
Inst Owners6.66%
Inst Owner Change0%
Ins Owners1.13%
Ins Owner Change0%
Market Cap4.36M
Revenue(TTM)N/A
Net Income(TTM)-35.80M
Analysts82.5
Price Target85.85 (4920.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)66.9%
Min EPS beat(2)64.27%
Max EPS beat(2)69.52%
EPS beat(4)4
Avg EPS beat(4)37.14%
Min EPS beat(4)3.29%
Max EPS beat(4)69.52%
EPS beat(8)6
Avg EPS beat(8)16.25%
EPS beat(12)9
Avg EPS beat(12)9.71%
EPS beat(16)12
Avg EPS beat(16)10.05%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-29.86%
PT rev (3m)2004.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-767.77%
EPS NY rev (1m)-2900%
EPS NY rev (3m)-1657.77%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-26.07
EYN/A
EPS(NY)-2.23
Fwd EYN/A
FCF(TTM)-14.58
FCFYN/A
OCF(TTM)-14.58
OCFYN/A
SpS0
BVpS-3.58
TBVpS-3.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -327.57%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-185.13%
ROA(5y)-125.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z -79.84
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)64.76%
Cap/Depr(5y)62.67%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-237.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.15%
EPS Next Y91.43%
EPS Next 2Y38.98%
EPS Next 3Y26.36%
EPS Next 5Y17.16%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.1%
EBIT Next 3Y11.61%
EBIT Next 5YN/A
FCF growth 1Y6.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.39%
OCF growth 3YN/A
OCF growth 5YN/A

APTOSE BIOSCIENCES INC / APTO FAQ

Can you provide the ChartMill fundamental rating for APTOSE BIOSCIENCES INC?

ChartMill assigns a fundamental rating of 1 / 10 to APTO.


What is the valuation status of APTOSE BIOSCIENCES INC (APTO) stock?

ChartMill assigns a valuation rating of 1 / 10 to APTOSE BIOSCIENCES INC (APTO). This can be considered as Overvalued.


Can you provide the profitability details for APTOSE BIOSCIENCES INC?

APTOSE BIOSCIENCES INC (APTO) has a profitability rating of 0 / 10.


What is the financial health of APTOSE BIOSCIENCES INC (APTO) stock?

The financial health rating of APTOSE BIOSCIENCES INC (APTO) is 1 / 10.


Can you provide the expected EPS growth for APTO stock?

The Earnings per Share (EPS) of APTOSE BIOSCIENCES INC (APTO) is expected to grow by 91.43% in the next year.